This week the largest medical testing company in the United States officially announced that they are going to begin offering breast cancer testing to the public using a radical new gene analysis method. The test is not new or particularly complicated and it is already used in some fashion by a few other companies but by adding in another testing company many doctors believe that the cost of breast cancer testing will likely go down dramatically.
Essentially the test analysis multiple genes found in a person’s DNA in order to detect abnormalities or strange occurrences that could develop into breast cancer. Doctors are quick to note that this is not a definitive test but it does in fact show whether a person is high risk or not for developing breast cancer. The good news is that because multiple companies will now be offering this preliminary screening the cost of the actual test will likely go down dramatically due to competition. Regardless of the price this is absolutely great news because millions of Americans will be able to get at least a glimpse of their genetic stance when it comes to breast cancer. No matter the results doctors encourage regular checkups, but this is still a good way to determine a person’s risk for breast cancer.